Literature DB >> 23692946

Traumatic brain injury: pathophysiology, monitoring, and mechanism-based care.

Richard B Arbour1.   

Abstract

Traumatic brain injury, which may be blunt or penetrating, begins altering intracranial physiology at the moment of impact as primary brain trauma. This article differentiates blunt versus penetrating brain trauma, primary versus secondary brain injury, and subsequent intracranial pathophysiology. Discussion and case study correlate intracranial pathophysiology and multisystem influences on evolving brain injury with mechanism-based interventions to modulate brain components (brain, blood, and cerebrospinal fluid volumes). The discussion also explores the effects of controlled ventilation, cardiopulmonary physiology, and global physiologic state on secondary injury, control of intracranial pressure, and recovery.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23692946     DOI: 10.1016/j.ccell.2013.02.010

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN: 0899-5885            Impact factor:   1.326


  3 in total

1.  Enhancing neural stem cell response to SDF-1α gradients through hyaluronic acid-laminin hydrogels.

Authors:  C P Addington; J M Heffernan; C S Millar-Haskell; E W Tucker; R W Sirianni; S E Stabenfeldt
Journal:  Biomaterials       Date:  2015-08-25       Impact factor: 12.479

Review 2.  Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration.

Authors:  Caroline P Addington; Adam Roussas; Dipankar Dutta; Sarah E Stabenfeldt
Journal:  Biomark Insights       Date:  2015-05-12

3.  Dramatic increases in blood glutamate concentrations are closely related to traumatic brain injury-induced acute lung injury.

Authors:  Wei Bai; Wan-Li Zhu; Ya-Lei Ning; Ping Li; Yan Zhao; Nan Yang; Xing Chen; Yu-Lin Jiang; Wen-Qun Yang; Dong-Po Jiang; Li-Yong Chen; Yuan-Guo Zhou
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.